AI-designed Universal Coronavirus Vaccine Passes First Human Trial
Reported byScienceDaily ↗·Sourced by Goodlede
Peer-reviewed clinical trial (Journal of Infection, 2026) with 39 healthy volunteers demonstrated vaccine safety and immune response generation against multiple Sarbeco coronaviruses including SARS-CoV-2. Published by University of Cambridge.
Phase 1 trial only (early-stage); further Phase 2 trials planned to assess broader efficacy in diverse populations.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at ScienceDaily
Read original story ↗↻ Refreshed daily
More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
Equality
Launch of Advancing Women's Rights and Gender Equality
Amman Center for Human Rights Studies · Verified
Science & Health
NHS Rolls Out Life-Extending Drug for Hundreds of Women with Ovarian Cancer
NHS England · Verified
Animals
European Commission Adopts Roadmap to Phase Out Animal Testing for Chemical Safety
European Commission via Rise for Animals · Verified